Senescence in premalignant tumours
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, in mice and humans, a senescence response to strong mitogenic signals, such as those delivered by certain oncogenes, prevents premalignant lesions from progressing to malignant cancers [ 16 – 19 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [16]
In the citing paper
“In addition to identifying known cell-cycle regulators, these studies identified DCR2 as a common marker of senescence (Collado et al., 2005), later shown to characterize other types of senescence.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [122]
In the citing paper
“This type of oncogene-induced senescence (OIS) is frequently observed in premalignant and benign tumour tissues [37 -39] but not in advanced malignant tumours, where cancer cells have already bypassed senescence.”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [38]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Self-citationTumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Self-citation
Cited by
Items 701–800 of 1,005
Hallmarks for senescence in carcinogenesis: novel signaling players
Caino, M. C., Meshki, J., & Kazanietz, M. G. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0316-z · Cited by 54
Senescence in the lesional fibroblasts of non-segmental vitiligo patients
Rani, S., Bhardwaj, S., Srivastava, N., Sharma, V. L., Parsad, D., & Kumar, R. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-016-1713-0 · Cited by 42
Marthandan, S., Menzel, U., Priebe, S., Groth, M., Guthke, R., Platzer, M., Hemmerich, P., Kaether, C., & Diekmann, S. (2016) · Biological Research · doi:10.1186/s40659-016-0095-2 · Cited by 39
Stra13 and Sharp-1, the Non-Grouchy Regulators of Development and Disease
Ow, J. R., Tan, Y. H., Jin, Y., Bahirvani, A. G., & Taneja, R. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-405943-6.00009-9 · Cited by 39
Tumor Dormancy, Oncogene Addiction, Cellular Senescence, and Self-Renewal Programs
Bellovin, D. I., Das, B., & Felsher, D. W. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-1445-2_6 · Cited by 39
“Cellular senescence is associated with permanent changes in gene expression, chromatin condensation, induction of cell cycle arrest programs that involve p15(INK4b), p16(INK4a) and/or p53, and is correlated with an increase in acidic beta-galactosidase enzymatic activity [67-71].”
BackgroundSenescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression
Zheng, H., Huang, Q., Huang, S., Yang, X., Zhu, T., Wang, W., Wang, H., He, S., Ji, L., Wang, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00519 · Cited by 40
“senescence is a critical physiological barrier against tumor progression (Collado et al., 2005).”
BackgroundKokal, M., Mirzakhani, K., Pungsrinont, T., & Baniahmad, A. (2020) · Cancers · doi:10.3390/cancers12071833 · Cited by 46
Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 42
Sherman, M. Y., Le, M., Stampfer, M. R., Gabai, V. L., & Yaglom, J. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00736.x · Cited by 41
“In line with this idea, there are many reports demonstrating that proliferative hyperplastic tissues and early tumors stain positive for SA-b-gal (Collado et al., 2005; Di Micco et al., 2006; Reddy et al., 2010).”
BackgroundWidespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia
Koorstra, J.-B. M., Hong, S., Shi, C., Meeker, A. K., Ryu, J. K., Offerhaus, G. J. A., Goggins, M., Hruban, R. H., & Maitra, A. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.114 · Cited by 44
“The potential role of mutant KRAS in DDR has emerged from a recent mouse model of pancreatic cancer mediated by expression of mutant Kras from its endogenous promoter, wherein markers attributable to senescence are observed in the murine PanIN lesions, but are lost upon progression to invasive adenocarcinoma, (21).”
BackgroundMouse models for BRAF-induced cancers
Pritchard, C. A., Carragher, L., Aldridge, V., Giblett, S. M., Jin, H., Foster, C., Andreadi, C., & Kamata, T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351329 · Cited by 48
p35 Is Required for CDK5 Activation in Cellular Senescence
Mao, D., & Hinds, P. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066118 · Cited by 44
CPEB Control of NF-κB Nuclear Localization and Interleukin-6 Production Mediates Cellular Senescence
Groppo, R., & Richter, J. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05133-11 · Cited by 39
“Senescence is a stress-induced cell cycle arrest that limits the proliferation of mitotic cells grown in culture (21) and suppresses tumor progression in vivo (5, 12).”
BackgroundChen, Y., Dokmanovic, M., Stein, W. D., Ardecky, R., & Roninson, I. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0581 · Cited by 41
“In fact, the only CDK inhibitor that we found to be up-regulated in retinoid-treated MCF-7 cells was p15 (CDKN2B), which was recently identified as a marker of oncogene-induced senescence (42).”
BackgroundAdvances in melanoma senescence and potential clinical application
Giuliano, S., Ohanna, M., Ballotti, R., & Bertolotto, C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00820.x · Cited by 47
“Senescence is commonly observed in pre-malignant lesions but not in malignant lesions, suggesting that senescence markers – acidic SA-b-Gal reactivity, the expression of cell cycle inhibitor (p14, p16, p21 and p27 for the most studied), the tumor suppressor p53, the active form of RB and the formation of SAHF – may be…”
BackgroundInfluentialRole of the Tripartite Motif Protein 27 in Cancer Development
Zoumpoulidou, G., Broceño, C., He, L., Bird, D., THOMAS, G. V., & Mittnacht, S. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs224 · Cited by 42
IPMK: A Versatile Regulator of Nuclear Signaling Events
Kim, E., Beon, J., Lee, S., Park, J., & Kim, S. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.11.005 · Cited by 39
Katamune, C., Koyanagi, S., Shiromizu, S., Matsunaga, N., Shimba, S., Shibata, S., & Ohdo, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706481 · Cited by 39
“In contrast to reversible cell-cycle arrest, cellular senescence is defined by the irreversible loss of proliferative potential, acquisition of a characteristic morphology, and expression of specific biomarkers, such as -gal (17, 18).”
BackgroundSenescence and pre-malignancy: How do tumors progress?
Saab, R. H. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.013 · Cited by 42
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 41
“The tumor-suppressive function of senescence relies on the postmitotic nature of senescent cells, which has been shown to act as a barrier against tumor progression in several tissues, including the colon, lung, lymphoma B cells, and pancreas (13, 18, 23, 28, 57).”
BackgroundZhao, Y., Wu, Z., Chanal, M., Guillaumond, F., Goehrig, D., Bachy, S., Principe, M., Ziverec, A., Flaman, J., Collin, G., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3763 · Cited by 40
The origins and functional effects of postzygotic mutations throughout the human life span
Rockweiler, N. B., Ramu, A., Nagirnaja, L., Wong, W., Noordam, M. J., Drubin, C. W., Huang, N., Miller, B., Todres, E. Z., Vigh‐Conrad, K. A., et al. (2023) · Science · doi:10.1126/science.abn7113 · Cited by 39
Song, N., Zhu, F., Wang, Z., Willette‐Brown, J., Xi, S., Sun, Z., Su, L., Wu, X., Ma, B., Nussinov, R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717520115 · Cited by 44
“Oncogenic Kras induces premalignant lesions by increasing cell senescence, as indicated by senescence-associated β-galactosidase (SA-β-gal) staining (30).”
BackgroundChen, Y.-L., Chen, Y.-J., Tsai, W.-H., Ko, Y.-C., Chen, J.-Y., & Lin, S.-F. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7411 · Cited by 37
Pare, R., Shin, J., & Lee, C. S. (2016) · Histopathology · doi:10.1111/his.12948 · Cited by 37
“Recent studies have shown that expression of senescence-associated markers is increased in premalignant lesions but lost in malignant lesions.(9) The aim of our study was to compare the expression profiles of the senescence markers p14, p16 and p21 at different morphological stages of development of invasive breast ca…”
BackgroundInsights into the role of senescence in tumor dormancy: mechanisms and applications
DeLuca, V. J., & Saleh, T. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10082-6 · Cited by 41
“In support of this, premalignant lesions of various tissues have previously been reported as having some proportion of senescent cells, as do drug-naïve patient tumors [37, 38].”
BackgroundSenescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Subedi, S., Guntipally, M., Suwal, N., Thapa, R., Bashyal, S., Panth, N., Gupta, G., MacLoughlin, R. J., Oliver, B. G. G., Dua, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102813 · Cited by 40
Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation
Grasso, D., Bintz, J., Lomberk, G. A., Molejon, M. I., Loncle, C., Garcia, M. N., López‐Millán, B., Urrutia, R. A., & Iovanna, J. (2015) · Scientific Reports · doi:10.1038/srep17549 · Cited by 37
Murphy, K. J., Chambers, C. R., Herrmann, D., Timpson, P., & Pereira, B. (2021) · Cancers · doi:10.3390/cancers13143481 · Cited by 45
Chen, J., Chen, K., Wang, L., Luo, J., Zheng, Q., & He, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04972-w · Cited by 42
Martínez, A. B., LÓPEZ-DURÁN, M., Cano‐Sánchez, J., Sánchez-Verde, L., DÍEZ-RODRÍGUEZ, A., AGUIRRE-ECHEBARRÍA, P., Álvarez‐Fernández, E., González‐Moles, M. Á., Bascones-Ilundáin, J., Muzio, L. L., et al. (2012) · Oncology Letters · doi:10.3892/ol.2012.649 · Cited by 42
“Cellular senescence and apoptosis are considered powerful tumour suppressor mechanisms through their control of the proliferative potential of cells (3).”
Zhu, C., Ikemoto, T., Utsunomiya, T., Yamada, S., Morine, Y., Imura, S., Arakawa, Y., Takasu, C., Ishikawa, D., & Shimada, M. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12468 · Cited by 40
A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest
Angus, S. P., & Nevins, J. R. (2012) · Oncogene · doi:10.1038/onc.2011.622 · Cited by 36
Tumor-Induced Myeloid-Derived Suppressor Cells
Sanctis, F. D., Bronte, V., & Ugel, S. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0016-2015 · Cited by 39
“Senescence is a characteristic of normal tissues and premalignant tumor cells; for example, while observed in pancreatic intraductal neoplasia and lung adenomas, it is absent in their advanced, malignant stages (105, 106).”
BackgroundTitration of RAS alters senescent state and influences tumour initiation
Chan, A. S. L., Zhu, H., Narita, M., Cassidy, L. D., Young, A. R. J., Bermejo‐Rodríguez, C., Janowska, A. T., Chen, H., Gough, S., Oshimori, N., et al. (2024) · Nature · doi:10.1038/s41586-024-07797-z · Cited by 38
Soo, J. K., Ross, A. D. M., Kallenberg, D. M., Milagre, C. S., Chong, W. H., Chow, J. W. M., Hill, L. J., Hoare, S. F., Collinson, R. S., Hossain, M., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00850.x · Cited by 41
“24; 490–503 ORIGINAL ARTICLE 2008; Collado et al., 2005; Mooi and Peeper, 2006; Stewart and Weinberg, 2006).”
DNA damage response in adult stem cells
Insinga, A., Cicalese, A., & Pelicci, P. G. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.12.005 · Cited by 41
Tanaka, N., Huttenhower, C., Nosho, K., Baba, Y., Shima, K., Quackenbush, J. F., Haigis, K. M., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100361 · Cited by 36
Organoids in Translational Oncology
Tatullo, M., Marrelli, B., Benincasa, C., Aiello, E., Im, M., Zavan, B., Ballini, A., Vito, D. D., & Spagnuolo, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092774 · Cited by 38
“The K-RAS pathway is amplified in colorectal cancer: in fact, abnormal K-RAS mutations can induce the hyperproliferation of the epithelium, resulting in the development of infiltrating adenocarcinomas [28].”
BackgroundFerreira-González, S., Man, T. Y., Esser, H., Aird, R. E., Kilpatrick, A. M., Rodrigo‐Torres, D., Younger, N. T., Campana, L., Gadd, V. L., Dwyer, B. J., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj4375 · Cited by 38
“Characterized by phenotypic alterations, including secretome changes and genomic instability, senescent cells up-regulate decoy receptor 2 (DCR2) (14, 15), a transmembrane receptor that belongs to the tumor necrosis factor receptor (TNFR) superfamily, and that is associated both with proapoptotic and antiapoptotic pat…”
BackgroundLee, S.-J., Lee, S.-H., Yoon, M.-H., & Park, B.-J. (2013) · Neoplasia · doi:10.1593/neo.121862 · Cited by 38
“[7] Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguría A,”
BackgroundFacts and fiction: premalignant lesions of lung tissues
Klebe, S., & Henderson, D. W. (2013) · Pathology · doi:10.1097/pat.0b013e32835f45fd · Cited by 36
At the stem of youth and health
Beltrami, A. P., Cesselli, D., & Beltrami, C. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.005 · Cited by 40
“More recently identified markers are: p16INK4A, DEC1, p15INK4B, and DCR2 (Collado et al., 2005), and the cytological markers: senescence-associated heterochromatin foci (SAHFs), and senescence-associated DNA damage foci (SDFs) (Narita et al., 2003; Di Micco et al., 2008).”
BackgroundEnhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma
Lazzarini, R., Moretti, S., Orecchia, S., Betta, P., Procopio, A. D., & Catalano, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0255 · Cited by 37
Braden, W. A., Lenihan, J. M., Lan, Z., Luce, K. S., Zagorski, W., Bosco, E., Reed, M. F., Cook, J. G., & Knudsen, E. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00045-06 · Cited by 35
“Based on recent data indicating that p16ink4a induction occurs in preneoplastic lesions as a potential barrier to cancer (14, 59), such lesions arising in p16ink4a-proficient and -deficient mice would represent an ideal setting for defining the involvement of p16ink4a loss in replication control in a”
BackgroundRetractedQu, K., Lin, T. Y., Wei, J., Meng, F., Wang, Z., Huang, Z., Wan, Y., Song, S., Liu, S., Chang, H., et al. (2013) · PubMed · Cited by 48
Pakuła, M., Mały, E., Uruski, P., Witucka, A., Bogucka, M., Jaroszewska, N., Makowska, N., Niklas, A., Moszyński, R., Sajdak, S., et al. (2020) · Cancers · doi:10.3390/cancers12020296 · Cited by 35
Autophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 42
Soto-Gamez, A., Wang, Y., Zhou, X., Seras, L., Quax, W. J., & Demaria, M. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.038 · Cited by 42
Celis, J. E., Moreira, J. M. A., Gromova, I., Cabezón, T., Gromov, P., Shen, T., Wielenga, V. T., & Rank, F. E. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.02.005 · Cited by 37
Cole, A. M., Ridgway, R. A., Derkits, S. E., Parry, L., Barker, N., Clevers, H., Clarke, A. R., & Sansom, O. J. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000101 · Cited by 37
“Recently, a role for activated Wnt signalling in renal carcinoma has been proposed, as the key renal tumour suppressor protein von Hippel-Lindau (VHL), acts through Jade-1, an E3 ubiquitin ligase, to target b-catenin for degradation (Zhou et al, 2005).”
BackgroundPirin Inhibits Cellular Senescence in Melanocytic Cells
Licciulli, S., Luise, C., Scafetta, G., Capra, M. C., Giardina, G., Nuciforo, P. G., Bòsari, S., Viale, G., Mazzarol, G., Tonelli, C., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.019 · Cited by 38
Senescence from glioma stem cell differentiation promotes tumor growth
Ouchi, R., Okabe, S., Migita, T., Nakano, I., & Seimiya, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.071 · Cited by 38
Upregulation of chicken p15INK4b at senescence and in the developing brain
Kim, S.-H., Rowe, J., Fujii, H., Jones, R., Schmierer, B., Kong, B.-W., Kuchler, K., Foster, D., Ish-Horowicz, D., & Peters, G. (2006) · Journal of Cell Science · doi:10.1242/jcs.02989 · Cited by 31
“…implicated are in stem cell self-renewal, particularly in the context of disrupted polycomb gene function (Valk-Lingbeek et al., 2004) and in the senescence-like state associated with premalignant lesions (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005).”
Induction of Transcriptionally Active Jun Proteins Regulates Drug-induced Senescence
Yogev, O., Anzi, S., Inoue, K., & Shaulian, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602865200 · Cited by 34
The tumor suppressor ING1 contributes to epigenetic control of cellular senescence
Abad, M., Moreno, A., Palacios, A., Narita, M., Blanco, F. J., Moreno‐Bueno, G., Narita, M., & Palmero, I. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00651.x · Cited by 44
“The relevance of oncogene-induced senescence as a tumor-protective barrier in vivo is now firmly established (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Courtois-Cox et al., 2006; Dankort et al., 2007).”
BackgroundRole of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers
Netti, G. S., Franzin, R., Stasi, A., Spadaccino, F., Strologo, A. D., Infante, B., Gesualdo, L., Castellano, G., Ranieri, E., & Stallone, G. (2021) · Cells · doi:10.3390/cells10092426 · Cited by 37
Yamaguchi, J., Sasaki, M., Harada, K., Zen, Y., Sato, Y., Ikeda, H., Itatsu, K., Yokoyama, Y., Ando, H., Ohta, T., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.65 · Cited by 35
“Senescence, particularly the telomere-independent form, is reported to act as a safeguard mechanism against malignant transformation.(16) For example, nevi composed of melanocytes showing cellular senescence may reside without malignant transformation for years.”
BackgroundZhao, X., Sun, J., Hu, Y., Yang, Y., Zhang, W., Hu, Y., Li, J., Sun, Y., Zhong, Y., Peng, W., et al. (2012) · Hearing Research · doi:10.1016/j.heares.2012.11.007 · Cited by 36
Bajaj, A., Zheng, Q., Adam, A. P., Vincent, P. A., & Pumiglia, K. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2648 · Cited by 34
“Oncogene-induced senescence was first shown in primary human fibroblasts (13), and subsequently, multiple reports describing the occurrence of this phenomenon both in vitro and in vivo (12, 14, 21, 35, 36) have appeared.”
Mesothelial cell: A multifaceted model of aging
Książek, K. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.01.008 · Cited by 35
MicroRNAs Regulate Key Effector Pathways of Senescence
Feliciano, A., Sánchez-Sendra, B., Kondoh, H., & LLeonart, M. E. (2011) · Journal of Aging Research · doi:10.4061/2011/205378 · Cited by 34
“Senescent cells are found in premalignant lesions in mice and humans, and they are absent in their corresponding malignant stages, which suggests a role for senescence as a barrier to tumor progression [35, 36].”
Dissecting cellular senescence and SASP in Drosophila
Ito, T., & Igaki, T. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0031-4 · Cited by 36
PTEN Mediates Activation of Core Clock Protein BMAL1 and Accumulation of Epidermal Stem Cells
Zagni, C., Almeida, L. O., Balan, T., Martins, M. A. T., Rosselli‐Murai, L. K., Papagerakis, P., CASTILHO, R. M., & SQUARIZE, C. H. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.006 · Cited by 34
“…is not enough to trigger hair cycle alterations and tumor development phenotype (White et al., 2014; Squarize et al., 2013; Chen et al., 2011; Kalaany and Sabatini, 2009), and cellular senescence usually occurs (White et al., 2014; Collado et al., 2005; Chen et al., 2005; Nardella et al., 2011).”
BackgroundThe Expanding Significance of Inositol Polyphosphate Multikinase as a Signaling Hub
Kim, E., Ahn, H., Kim, M. G., Lee, H., & Kim, S. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.0066 · Cited by 36
“p53 is a well-known tumor suppressor that senses diverse stress signals and regulates gene expression to cause cell cycle arrest, cellular senescence, and apoptosis (Brady and Attardi, 2010; Chen et al., 2005; Collado et al., 2005; Vousden and Prives, 2009).”
BackgroundCellular senescence in oral cancer and precancer and treatment implications: A review
Campo, J., Cano‐Sánchez, J., Palacios-Sánchez, B., Llamas-Martínez, S., Muzio, L. L., & Martínez, A. B. (2008) · Acta Oncologica · doi:10.1080/02841860802183612 · Cited by 37
“These markers were verified in premalignant lesions in skin, lung, and pancreas from mice with H-ras and K-ras mutations [20], and may be also useful in oral premalignant lesions.”
BackgroundInfluentialReduced risk of head and neck second primary tumors after radiotherapy
Rennemo, E., Zätterström, U. K., Evensen, J. F., & Boysen, M. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.08.005 · Cited by 34
“Alternatively, the radiotherapy may have brought existing premalignant lesions into accelerated senescence [15,16], a state that has been shown to be reversible [17,18].”
BackgroundRetinoblastoma Loss Modulates DNA Damage Response Favoring Tumor Progression
Seoane, M., Iglesias, P., González, T., Domínguez, F., Fraga, M., Aliste, C., Forteza, J., & Costoya, J. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003632 · Cited by 37
“DDR is likely to be related to premalignant neoplastic lesions in human [18,39–41], and has been linked to increased expression levels of p16 and p19 [18], which appear mutated in a vast proportion of GBMs [31].”
BackgroundRusso, M., Moccia, S., Luongo, D., & Russo, G. L. (2023) · Cancers · doi:10.3390/cancers15092660 · Cited by 35
“Specifically, senescence represents an important negative player in cancer therapy, maintaining resistance to apoptosis and supporting chronic inflammation in premalignant tumors [17].”
BackgroundFunctional and structural insights into RAS effector proteins
Mozzarelli, A. M., Simanshu, D. K., & Castel, P. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.06.027 · Cited by 40
Wang, T., Li, Y., Wang, W., Tuerhanjiang, A., Wu, Z., Yang, R., Yuan, M., Ma, D., Wang, W., & Wang, S. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.05.001 · Cited by 34
“Recently, several EMT-inducing transcription factors have been shown to mitigate the effects of senescence [6], which can be characterized by the accumulation of Chromobox homolog 3 (CBX3,HP1γ), a marker of senescence-associated heterochromatin foci [7,8].”
BackgroundThe ups and downs of p53 regulation in hematopoietic stem cells
Abbas, H. A., Pant, V., & Lozano, G. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17721 · Cited by 33
Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer
Alexander, P. B., Chen, R., Gong, C., Yuan, L., Jasper, J. S., Ding, Y., Markowitz, G. J., Yang, P., Xu, X., McDonnell, D. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754960 · Cited by 36
Targeting LINC00673 expression triggers cellular senescence in lung cancer
Roth, A., Boulay, K., Groß, M., Polycarpou‐Schwarz, M., Mallette, F. A., Regnier, M., Bida, O., Ginsberg, D., Warth, A., Schnabel, P. A., et al. (2018) · RNA Biology · doi:10.1080/15476286.2018.1553481 · Cited by 36
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Fuhrmann-Stroissnigg, H., Santiago, F. E., Grassi, D., Ling, Y., Niedernhofer, L. J., & Robbins, P. D. (2019) · Journal of Visualized Experiments · doi:10.3791/58133 · Cited by 30
Gene regulation and tumor suppression by the bromodomain-containing protein BRD7
Mantovani, F., Drost, J., Voorhoeve, P. M., Sal, G. D., & Agami, R. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12309 · Cited by 34
Berman, H. K., Gauthier, M. L., & Tlsty, T. D. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0073 · Cited by 36
“Studies in human samples (2) and murine models of prostate carcinogenesis (56), melanocytic nevi (57–59), lung adenomas (60, 61), and lymphoma (62) show that overexpression of p16 protein and other markers of cellular senescence preferentially identify indolent premalignant and benign lesions.”
BackgroundStem Cell Ageing and Apoptosis
Fulle, S., Centurione, L., Mancinelli, R., Sancilio, S., Manzoli, F. A., & Pietro, R. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799859657 · Cited by 34
“More recently identified markers include p16, DEC1, p15, DCR2 [67] and the cytological markers: senescence-associated heterochromatin foci (SAHFs) and senescence-associated DNA damage foci (SDFs) [68, 69].”
BackgroundThe Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells
Delestré, L., Cui, H., Esposito, M., Quiveron, C., Mylonas, E., Penard-Lacronique, V., Bischof, O., & Guillouf, C. (2017) · Haematologica · doi:10.3324/haematol.2016.157636 · Cited by 32
“Oncogene-induced senescence (OIS) is a mechanism that limits cell hyperproliferation through a stable cell cycle arrest process,(29) thus blocking the expansion of cells at the pre-cancerous stage in solid tumors.(30,31) The expression of the hematopoietic oncogenes HRAS, BCR-ABL, CBFBMYH11 or RUNX1-ETO in primary HSC…”
BackgroundOta, K., Brydun, A., Itoh‐Nakadai, A., Sun, J., & Igarashi, K. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/757901 · Cited by 32
“Cellular senescence is induced byROS throughDNAdamage responses and acts as a barrier againstmalignant transformation of damaged cells [34, 35].”
BackgroundTherapy-induced microenvironmental changes in cancer
Ma, Y., Yang, H., Pitt, J. M., Kroemer, G., & Zitvogel, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1401-8 · Cited by 35
“Senescence is prevalently discovered in premalignant tissues but is usually absent from neoplastic lesions, indicating that senescence may act as an intrinsic barrier for malignant progression [24, 25].”
BackgroundDharmarajan, K. V., Presley, C. J., & Wyld, L. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_319841 · Cited by 34
Zhu, H., Chan, K. T., Huang, X., Cerra, C., Blake, S., Trigos, A., Anderson, D., Creek, D. J., Souza, D. P. D., Wang, X., et al. (2022) · eLife · doi:10.7554/elife.71929 · Cited by 38
Volonté, D., Sedorovitz, M., & Galbiati, F. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102405 · Cited by 36
Chojak, R., Fares, J., Petrosyan, E., & Lesniak, M. S. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04387-3 · Cited by 35
Ma, Y., Lü, B., Ruan, W., Wang, H., Lin, J., Hu, H., Deng, H., Huang, Q., & Lai, M. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.04.005 · Cited by 34
Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models
Blanco-Aparicio, C., Cañamero, M., Cecilia, Y., Pequeño, B., Renner, O., Ferrer, I., & Carnero, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009305 · Cited by 31
“It has been proposed that the activation of AKT triggers a senescent checkpoint blocking the progression to full grown tumors [30,32].”
BackgroundMeyer, M., Rübsamen, D., Slany, R. K., Illmer, T., Stabla, K., Roth, P., Stiewe, T., Eilers, M., & Neubauer, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007768 · Cited by 32
“In non-hematopoietic cells such as primary fibroblasts, oncogenic RAS induces a permanent growth arrest termed senescence, which limits RAS-induced tumorigenesis in vivo [19–23].”
BackgroundRadiloff, D. R., Wakeman, T. P., Feng, J., Schilling, S. H., Seto, E., & Wang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017269108 · Cited by 32
Yang, H.-S., & Hinds, P. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3141 · Cited by 36
Li, J., Sejas, D. P., Burma, S., Chen, D. J., & Pang, Q. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm025 · Cited by 34
Molecular Mechanisms Underlying Pituitary Pathogenesis
Sapochnik, M., Nieto, L., Fuertes, M., & ARZT, E. S. (2015) · Biochemical Genetics · doi:10.1007/s10528-015-9709-6 · Cited by 33
“…human dermal neurofibromas (Courtois-Cox et al. 2006), human and murine prostatic adenomas (Chen et al. 2005), murine pancreatic intraductal neoplasias (Collado et al. 2005), murine lymphomas (Braig et al. 2005), and early murine melanomas (Ha et al. 2007), but not in malignant adenocarcinomas.”
BackgroundIglesias–Ara, A., Zenarruzabeitia, O., Fernández‐Rueda, J., Sànchez‐Tilló, E., Field, S. J., Celada, A., & Zubiaga, A. M. (2010) · Oncogene · doi:10.1038/onc.2010.296 · Cited by 33
Calcium and Nuclear Signaling in Prostate Cancer
Maly, I. V., & Hofmann, W. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041237 · Cited by 32
“A consistent interpretation may be possible, stemming from the fact that DcR2 is, at the same time, an established senescence marker [121,122].”
BackgroundAccumulation of senescent cells in the stroma of aged mouse ovary
Maruyama, N., FUKUNAGA, I., Tomoaki, K. O. G. O., Endo, T., Fujii, W., Kanai‐Azuma, M., Naito, K., & Sugiura, K. (2023) · Journal of Reproduction and Development · doi:10.1262/jrd.2023-021 · Cited by 33
Failsafe program escape and EMT: A deleterious partnership
Ansieau, S., Courtois-Cox, S., Morel, A., & Puisieux, A. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.014 · Cited by 36
PML links aberrant cytokine signaling and oncogenic stress to cellular senescence
Bourdeau, V. (2009) · Frontiers in Bioscience · doi:10.2741/3256 · Cited by 30
“These pioneering experiments in the tissue culture environment have been recently validated in vivo with the discovery that senescence limits oncogenic activity in mice and that senescent cells accumulate in benign tumors both in humans and mice (5-7).”
BackgroundRadiation Induced Bystander Effect: From in Vitro Studies to Clinical Application
Wideł, M. (2016) · International Journal of Medical Physics Clinical Engineering and Radiation Oncology · doi:10.4236/ijmpcero.2016.51001 · Cited by 219
“Initially, cellular senescence was believed to be a side effect of culturing cells in vitro, but recently senescent cells have also been found in vivo in a variety of tissues and organs in response to different stress, among them ionizing radiation [21].”
Background
Metadata
- Authors
- Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., Beach, D., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Imperial College London (GB)
- Consejo Superior de Investigaciones Científicas (ES)
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Serrano, Manuel
- ORCID
- Venue
- Nature
- Published
- 2005-08-04
- Volume
- 436
- Issue
- 7051
- Pages
- 642-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067117191
- Cited by
- 1,482
- References
- 7
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 59 · 2023: 58 · 2022: 57 · 2021: 74 · 2020: 87 · 2019: 55 · 2018: 53 · 2017: 68 · 2016: 67 · 2015: 73 · 2014: 76 · 2013: 81 · 2012: 81
- FWCI
- 46.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, oncogene-induced senescence, oncogenic Ras, lymphoma, SUV39H1, histone methyltransferase, epigenetic regulation, melanoma, p53, PTEN mutation, prostate cancer, tumor suppression, cancer diagnosis and prognosis
- MeSH terms
- Adenocarcinoma, Alleles, Animals, beta-Galactosidase, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lung Neoplasms, Mice, Transgenic, Precancerous Conditions, Genes, ras, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Cellular Senescence, Disease Progression, Cyclin-Dependent Kinase Inhibitor p16, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.